# Mack Roach

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/mack-roach/

## Facts

| Field | Value |
| --- | --- |
| Citations | 30,931 |
| Field | Prostate Cancer Diagnosis and Treatment |
| h-index | 84 |
| i10-index | 274 |
| Last Known Institution | University of California San Francisco Medical Center |
| OpenAlex ID | https://openalex.org/A5089472018 |
| ORCID iD | 0000-0002-3546-8565 |
| Works | 639 |

## Researcher papers

Showing 12 of 14.

- [Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference](https://scholariq.org/papers/defining-biochemical-failure-following-radiotherapy-with-or-without-hormonal/)
- [Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology](https://scholariq.org/papers/prostate-cancer-version-2-2019-nccn-clinical-practice-guidelines-in-oncology/)
- [Prostate Cancer](https://scholariq.org/papers/prostate-cancer-2/)
- [Randomized Trial of Short- Versus Long-Course Radiotherapy for Palliation of Painful Bone Metastases](https://scholariq.org/papers/randomized-trial-of-short-versus-long-course-radiotherapy-for-palliation-of/)
- [Prostate Cancer, Version 1.2016](https://scholariq.org/papers/prostate-cancer-version-1-2016/)
- [Short-Term Neoadjuvant Androgen Deprivation Therapy and External-Beam Radiotherapy for Locally Advanced Prostate Cancer: Long-Term Results of RTOG 8610](https://scholariq.org/papers/short-term-neoadjuvant-androgen-deprivation-therapy-and-external-beam/)
- [Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017](https://scholariq.org/papers/management-of-patients-with-advanced-prostate-cancer-the-report-of-the-advanced/)
- [Phase III Trial Comparing Whole-Pelvic Versus Prostate-Only Radiotherapy and Neoadjuvant Versus Adjuvant Combined Androgen Suppression: Radiation Therapy Oncology Group 9413](https://scholariq.org/papers/phase-iii-trial-comparing-whole-pelvic-versus-prostate-only-radiotherapy-and/)
- [Prostate Cancer, Version 4.2023, NCCN Clinical Practice Guidelines in Oncology](https://scholariq.org/papers/prostate-cancer-version-4-2023-nccn-clinical-practice-guidelines-in-oncology/)
- [NCCN Guidelines Insights: Prostate Cancer, Version 1.2021](https://scholariq.org/papers/nccn-guidelines-insights-prostate-cancer-version-1-2021/)
- [Association of Black Race With Prostate Cancer–Specific and Other-Cause Mortality](https://scholariq.org/papers/association-of-black-race-with-prostate-cancer-specific-and-other-cause/)
- [Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019](https://scholariq.org/papers/management-of-patients-with-advanced-prostate-cancer-report-of-the-advanced/)

## Researcher topics

- [Prostate Cancer Diagnosis and Treatment](https://scholariq.org/topics/prostate-cancer-diagnosis-and-treatment/)
- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)
- [Advanced Radiotherapy Techniques](https://scholariq.org/topics/advanced-radiotherapy-techniques/)
- [Radiation Therapy and Dosimetry](https://scholariq.org/topics/radiation-therapy-and-dosimetry/)
- [Radiomics and Machine Learning in Medical Imaging](https://scholariq.org/topics/radiomics-and-machine-learning-in-medical-imaging/)

## Researcher university

- [University of California San Francisco Medical Center](https://scholariq.org/institutions/university-of-california-san-francisco-medical-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.